Key result
Fibrates and thiazolidinediones lower triglycerides through distinct tissue-specific mechanisms, with fibrates reducing apo C-III in the liver via PPAR-alpha and thiazolidinediones inducing LPL in adipose tissue via PPAR-gamma.
Design
Review
Authors
Loading...
Should not change TG-lowering practice; leaves open whether distinct PPAR pathways yield differential outcomes.
Fibrates and thiazolidinediones exert their hypotriglyceridemic effects through distinct, tissue-specific transcriptional regulation of lipid metabolism genes via different PPAR subtypes.
Auwerx et al. (1996) conducted a review in Hypertriglyceridemia. Fibrates and Thiazolidinediones was evaluated. Fibrates and thiazolidinediones lower triglycerides through distinct tissue-specific mechanisms, with fibrates reducing apo C-III in the liver via PPAR-alpha and thiazolidinediones inducing LPL in adipose tissue via PPAR-gamma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: